53938-24-2

Basic information

• Product Name: 1-bromo-4,5-dimethyl-2-nitrobenzene
• Synonyms: 1-bromo-4,5-dimethyl-2-nitrobenzene;2-Bromo-4,5-dimethylnitrobenzene;4-Bromo-5-nitro-o-xylene
• CAS NO: 53938-24-2
• Molecular Formula: C₈H₈BrNO₂
• Molecular Weight: 230.05862
• Mol File: 53938-24-2.mol
• Article Data: 8

Chemical Properties

• Melting Point: 58-60℃
• Boiling Point: 291℃
• Flash Point: 130℃
• Appearance: /
• Density: 1.533
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-bromo-4,5-dimethyl-2-nitrobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-bromo-4,5-dimethyl-2-nitrobenzene(53938-24-2)
• EPA Substance Registry System: 1-bromo-4,5-dimethyl-2-nitrobenzene(53938-24-2)

Safety Data

• Hazardous Substances Data: 53938-24-2(Hazardous Substances Data)

Usage

General Description

1-bromo-4,5-dimethyl-2-nitrobenzene is a chemical compound with the molecular formula C8H8BrNO2. It is a derivative of benzene with a bromine and nitro group attached to the carbon ring. The compound is a yellow solid and is mainly used as an intermediate in the synthesis of various organic compounds. It is also used in the production of pharmaceuticals, agrochemicals, and dyes. 1-bromo-4,5-dimethyl-2-nitrobenzene is considered to be a hazardous chemical and requires careful handling and storage due to its reactive nature and potential health effects.

Upstream product

• 6972-71-0 4,5-dimethyl-2-nitrobenzenamine 
• 583-71-1 4-bromo-o-xylene 
• 99-51-4 4-nitro-o-xylene 

Downstream Products

• 81614-97-3 4,5-Dimethyl-2-phenoxy-nitrobenzol 
• 1242840-80-7 5-(4,5-dimethyl-2-nitro-phenyl)-furan-2-carbaldehyde 
• 1338685-23-6 N-[2-(benzyloxy)-3-phenylpropyl]-4,5-dimethyl-2-nitroaniline 
• 1338684-81-3 N-(2-isopropoxy-3-phenylpropyl)-4,5-dimethyl-2-nitroaniline 
• 1338685-20-3 10-[2-(benzyloxy)-3-phenylpropyl]-7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione 
• 1338685-24-7 N-[2-(benzyloxy)-3-phenylpropyl]-4,5-dimethylbenzene-1,2-diamine 
• 1338685-11-2 10-(2-(benzylamino)-3-phenylpropyl)-7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione 
• 1338684-80-2 10-(2-isopropoxy-3-phenylpropyl)-7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione 
• 1338684-83-5 N-(2-isopropoxy-3-phenylpropyl)-4,5-dimethylbenzene-1,2-diamine 
• 1338684-71-1 10-(2-amino-3-phenylpropyl)-7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione 
• 1338684-74-4 tert-butyl (1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-3-phenylpropan-2-yl)carbamate 
• 1338684-73-3 tert-butyl (1-((2-amino-4,5-dimethylphenyl)amino)-3-phenylpropan-2-yl)carbamate 
• 1338684-56-2 10-[3-(4-chlorophenyl)propyl]-7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione 
• 1338684-58-4 N-[3-(4-chlorophenyl)propyl]-4,5-dimethylbenzene-1,2-diamine 

Relevant articles and documents

Histone acetyltransferase P300 small molecule inhibitor and medicinal composition and application thereof

The compound capable of inhibiting histone acetyltransferase, has a significant inhibition effect p300 in inhibiting the activity, of the histone acetyltransferase, or a pharmaceutically acceptable salt (I) of; has a significant inhibitory effect on tumor cells such as the primary, representative small molecule inhibitor p300 to prostate cancer cells, malignant blood tumor cells p300 breast cancer cells, and has an effect of inhibiting the toxicity C646, of the compound by overcoming the defects, of the original, small molecule inhibitor, existing in the present invention. C646 p300. The compounds of the formula C646; are shown in, Table (I). The invention belongs to, the field of pharmaceutical chemistry.

Methods and Compositions for Modulating P300/CBP Activity

The present invention relates to a method for identifying compounds that modulate the activity of p300/CBP. Compounds of the invention are identified by designing or screening for a compound which binds to at least one amino acid residue of the newly identified lysine-CoA inhibitor binding site, L1 loop, electronegative pocket, or electronegative groove of the HAT domain of p300/CBP and testing the compound for its ability to modulate the activity of p300/CBP. Compositions and methods for preventing or treating diseases or disorders associated with p300/CBP are also provided as is a method for producing a semi-synthetic HAT domain.

4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM

The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides 4,4-(disubstituted)piperidine derivatives represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C1-C6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.